ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Prof Eggermont hosts a press conference at ESMO 2014 about the Cancer Core Europe initiative, which looks to collate data and research from six key European cancer centres to create a fully integrated and collaborative 'e-hospital'.
Here, Prof Piris gives an overview of the Netherlands Cancer Institute and its place within the Cancer Core Europe initiative.
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Synthetic biology and precision medicine in blood and gynaecological cancers
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
Choosing Wisely to mitigate financial toxicity in cancer care in Africa